Login / Signup

A novel CYCS mutation in the α-helix of the CYCS C-terminal domain causes non-syndromic thrombocytopenia.

Yuri UchiyamaKunio YanagisawaShinji KunishimaMasaaki ShiinaYoshiyuki OgawaMitsuko NakashimaJunko HiratoEri ImagawaAtsushi FujitaKohei HamanakaSatoko MiyatakeSatomi MitsuhashiAtsushi TakataNoriko MiyakeKazuhiro OgataHiroshi HandaNaomichi MatsumotoTakeshi Mizuguchi
Published in: Clinical genetics (2018)
We report a patient with thrombocytopenia from a Japanese family with hemophilia A spanning four generations. Various etiologies of thrombocytopenia, including genetic, immunological, and hematopoietic abnormalities, determine the prognosis for this disease. In this study, we identified a novel heterozygous mutation in a gene encoding cytochrome c, somatic (CYCS, MIM123970) using whole exome sequencing. This variant (c.301_303del:p.Lys101del) is located in the α-helix of the cytochrome c (CYCS) C-terminal domain. In silico structural analysis suggested that this mutation results in protein folding instability. CYCS is one of the key factors regulating the intrinsic apoptotic pathway and the mitochondrial respiratory chain. Using the yeast model system, we clearly demonstrated that this one amino acid deletion (in-frame) resulted in significantly reduced cytochrome c protein expression and functional defects in the mitochondrial respiratory chain, indicating that the loss of function of cytochrome c underlies thrombocytopenia. The clinical features of known CYCS variants have been reported to be confined to mild or asymptomatic thrombocytopenia, as was observed for the patient in our study. This study clearly demonstrates that thrombocytopenia can result from CYCS loss-of-function variants.
Keyphrases
  • copy number
  • amino acid
  • oxidative stress
  • cell death
  • genome wide
  • gene expression
  • autism spectrum disorder
  • small molecule
  • anti inflammatory